Sonova downgrades, blames high costs and weak results from key markets
![Photo: Sonova / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14025650.ece/ALTERNATES/schema-16_9/doc7l130af3j7aoln0n1b5.jpg)
The developments on certain key markets have been weaker than expected for the world’s largest hearing aid manufacturer, Sonova, in the first few months of its 2022/23 accounting year.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Demant downgrades after revenue disappoints
For subscribers
WS Audiology establishes business unit for the Americas
For subscribers